Why the study?
In vitro fertilization pregnancies without a corpus luteum show deficient first-trimester arterial compliance increases and higher preeclampsia risk, but generalized impairment of maternal cardiovascular adaptation remained uninvestigated.
Does in vitro fertilization without a corpus luteum impair maternal cardiovascular adaptation in early pregnancy compared to pregnancies with 1 or >1 corpus luteum?
Does in vitro fertilization without a corpus luteum impair maternal cardiovascular adaptation in early pregnancy compared to pregnancies with 1 or >1 corpus luteum?
Pregnancies conceived via IVF without a corpus luteum exhibit impaired maternal cardiovascular adaptation in early gestation, highlighting the potential need for CL factor replacement to reduce preeclampsia risk.
Commonly used in vitro fertilization protocols produce pregnancies without a corpus luteum (CL), a major source of reproductive hormones. In vitro fertilization pregnancies without a CL showed deficient gestational increases of central (aortic) arterial compliance during the first trimester and were at increased risk for developing preeclampsia. Here, we investigated whether there was generalized impairment of cardiovascular adaptation in in vitro fertilization pregnancies without a CL compared with pregnancies conceived spontaneously or through ovarian stimulation, which lead to 1 and >1 CL, respectively (n=19-26 participants per cohort). Prototypical maternal cardiovascular adaptations of gestation were serially evaluated noninvasively, initially during the follicular phase before conception, 6× in pregnancy, and then, on average, 1.6 years post-partum. The expected increases of cardiac output, left atrial dimension, peak left ventricular filling velocity in early diastole (E wave velocity), peripheral/central arterial pulse pressure ratio, and global AC, as well as decrease in augmentation index were significantly attenuated or absent during the first trimester in women who conceived without a CL, when compared with the 1 and >1 CL cohorts, which were comparable. Thereafter, these cardiovascular measures showed recovery in the 0 CL group except for E wave velocity, which remained depressed. These results provided strong support for a critical role of CL factor(s) in the transformation of the maternal cardiovascular system in early gestation. Regimens that lead to the development of a CL or replacement of missing CL factor(s) may be indicated to improve cardiovascular function and reduce preeclampsia risk in in vitro fertilization pregnancies.
No takes yet. Share an insight, caveat, or question.
Conrad et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: